Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2020-08-21 Sale |
2020-08-25 7:10 pm |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
7,303 | $112.86 | $824,190 | 284,170 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2020-08-21 Exercise |
2020-08-25 7:10 pm |
N/A 2022-02-09 |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
8,093 | $0 | 284,170 (Direct) |
View |
2020-08-24 Exercise |
2020-08-25 7:10 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
78 | $21.92 | 284,170 (Direct) |
View |
2020-08-21 Exercise |
2020-08-25 7:10 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
7,225 | $14.47 | 284,170 (Direct) |
View |
2020-08-21 Exercise |
2020-08-25 7:10 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
790 | $74.42 | 284,170 (Direct) |
View |
2020-07-07 Exercise |
2020-07-09 4:28 pm |
N/A 2025-02-10 |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
4,315 | $0 | 406,845 (Direct) |
View |
2020-07-07 Exercise |
2020-07-09 4:28 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
1,165 | $85.79 | 406,845 (Direct) |
View |
2020-07-07 Exercise |
2020-07-09 4:28 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
1,777 | $56.26 | 406,845 (Direct) |
View |
2020-07-07 Exercise |
2020-07-09 4:28 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
1,373 | $74.42 | 406,845 (Direct) |
View |
2020-06-30 Other |
2020-07-01 8:06 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
238 | $89.03 | 41,353 (Direct) |
View |
2020-06-30 Other |
2020-07-01 8:05 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
238 | $89.03 | 26,174 (Direct) |
View |